{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:58:53Z","timestamp":1761821933797,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.rec.2019.12.022","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T14:42:22Z","timestamp":1587998542000},"page":"452-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comments on the 2019 ESC guidelines on acute pulmonary embolism"],"prefix":"10.1016","volume":"73","member":"78","reference":[{"key":"10.1016\/j.rec.2019.12.022_bib0085","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz726","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.12.022_bib0090","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.12.022_bib0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2019.12.022_bib0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.recesp.2019.01.002","article-title":"Uso del oxigenador extracorp\u00f3reo de membrana venoarterial en pacientes con tromboembolia pulmonar de alto riesgo","volume":"72","author":"Luna-L\u00f3pez","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.12.022_bib0105","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.rec.2019.12.022_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2019.12.022_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.thromres.2018.05.031","article-title":"Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: a propensity-score weighted administrative claims cohort study","volume":"168","author":"Coleman","year":"2018","journal-title":"Thromb Res."},{"key":"10.1016\/j.rec.2019.12.022_bib0120","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"EINSTEIN\u2013PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2019.12.022_bib0125","first-page":"CD006771","article-title":"Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rec.2019.12.022_bib0130","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CBER). FDA Guidance for industry: non-Inferiority Clinical Trials to Establish Effectiveness Guidance for Industry. 2016. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/non-inferiority-clinical-trials. Consultado 5 Oct 2019."},{"issue":"Suppl 2","key":"10.1016\/j.rec.2019.12.022_bib0135","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.rec.2019.12.022_bib0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.115.016930","article-title":"SURVET Study Investigators. Sulodexide for the prevention of recurrent venous thromboembolism: the Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) study: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"132","author":"Andreozzi","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2019.12.022_bib0145","first-page":"51","article-title":"Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism","author":"Coquoz","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.rec.2019.12.022_bib0150","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02522-2016","article-title":"Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension","author":"Simonneau","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.rec.2019.12.022_bib0155","first-page":"49","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.rec.2019.12.022_bib0160","first-page":"224","article-title":"Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Observational study in a referral unit","volume":"72","author":"Vel\u00e1zquez Mart\u00edn","year":"2019","journal-title":"Rev Esp Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585720301195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585720301195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:57:34Z","timestamp":1761821854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585720301195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1885585720301195"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2019.12.022","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comments on the 2019 ESC guidelines on acute pulmonary embolism","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2019.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2020.05.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}